BNTC (Benitec Biopharma Inc. Common Stock) Stock Analysis - AI Report
Benitec Biopharma Inc. Common Stock (BNTC) is a publicly traded Healthcare sector company. As of May 21, 2026, BNTC trades at $10.99 with a market cap of $374.12M and a P/E ratio of -10.37. BNTC moved +2.99% today. Year to date, BNTC is -7.57%; over the trailing twelve months it is -21.11%. Its 52-week range spans $8.49 to $17.15. Analyst consensus is strong buy with an average price target of $25.00. Rallies surfaces BNTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on BNTC?
Rallies AI research for BNTC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Rallies AI research for BNTC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for BNTC?
Rallies AI research for BNTC combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is BNTC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BNTC. It does not provide personalized investment advice.